Inhibition of THP-1 cell-mediated low-density lipoprotein oxidation by the macrophage-synthesised pterin, 7,8-dihydroneopterin

REFERENCES

• Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–924.
   PubMed Web of Science ®Google Scholar
• Hoff HF, O'Neil J. Lesion-derived low density lipoprotein and oxidised low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Arterioscler Thromb 1991; 11: 1209–1222.
   PubMed Web of Science ®Google Scholar
• Upston JM, Niu X, Brown AJ et al. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am J Pathol 2002; 160: 710–720.
   Web of Science ®Google Scholar
• Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984; 81: 3883–3887.
   PubMed Web of Science ®Google Scholar
• Heinecke JW, Baker L, Rosen H, Chait A. Superoxide-mediatedmodification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest 1986; 77: 757–761.
   PubMed Web of Science ®Google Scholar
• Jessup W, Rankin SM, De Whalley CV, Hoult RS, Scott J. Alpha-tocopherol consumption during low density lipoprotein oxidation. Biochem J 1990; 265: 399–405.
   PubMed Web of Science ®Google Scholar
• Aviram M, Rosenblat M, Etzioni A, Levy R. Activation of NADPH oxidase is required for macrophage mediated oxidation of low density lipoprotein. Metabolism 1996; 45: 1069–1079.
   PubMed Web of Science ®Google Scholar
• Werner ER, Werner-Felmayer G, Fuchs D et al. Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1 and T 24 cells. J Biol Chem 1990; 265: 3189–3192.
   PubMed Web of Science ®Google Scholar
• Muller MM, Curtis H, Herold M, Huber CH. Neopterin in clinical practice. Clin Chim Acta 1991; 201: 1–16.
   PubMed Web of Science ®Google Scholar
• Schumacher M, Eder B, Tatzber F, Kaufmann P. Esterbauer H, Klein W. Neopterin levels in patients with coronary artery disease. Atherosclerosis 1992; 94: 87–88.
   PubMed Web of Science ®Google Scholar
• Kojima S, Nomura T, Icho T, Kajiwara Y, Kitabatake K, Kubota K. Inhibitory effects of neopterin on NADPH-dependent superoxide-generating oxidase of rat peritoneal macrophages. FEBS Lett 1993; 329: 125–128.
   PubMed Web of Science ®Google Scholar
• Gieseg SP, Glubb D, Maghzal G. Protection of erythrocytes by the macrophage synthesized antioxidant 7,8 dihydroneopterin. Free Radic Res 2001; 34: 123–136.
   PubMed Web of Science ®Google Scholar
• Oettl K, Wirleitner B, Baier BG, Grammer T, Fuchs D, Reibnegger G. Formation of oxygen radicals in solutions of 7,8-dihydroneopterin. Biochem Biophys Res Commun 1999; 264: 262–267.
   PubMed Web of Science ®Google Scholar
• Schobersterger W, Hoffmann G, Hobisch-Hagen P et al. Neopterin and 7,8-dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line L2. FEBS Lett 1996; 397: 263–268.
   PubMed Web of Science ®Google Scholar
• Gieseg SP, Whybrow J, Glubb D, Rait C. Protection of U937 cells from free radical damage by the macrophage synthesized antioxidant 7,8 dihydroneopterin. Free Radic Res 2001; 35: 311–318.
   PubMed Web of Science ®Google Scholar
• Gieseg SP, Reibnegger G, Wachter H, Esterbauer H. 7,8-Dihydroneopterin inhibits low density lipoprotein oxidation in vitro. Evidence that this macrophage secreted pteridine is an anti-oxidant. Free Radic Res 1995; 23: 123–136.
   PubMed Web of Science ®Google Scholar
• Graham A, Wood JL, O'Leary VJ, Stone D. Human (THP-1) macrophages oxidise LDL by a thiol-dependent mechanism. Free Radic Res 1994; 21: 295–308.
   PubMed Web of Science ®Google Scholar
• Fernando FL, Varghese Z, Moorhead JF. Differential ability of cells to promote oxidation of low-density lipoproteins in vitro. Clin Chim Acta 1998; 269: 159–173.
   PubMed Web of Science ®Google Scholar
• Jessup W, Simpson JA, Dean RT. Does superoxide radical have a role in macrophage-mediated oxidative modification of LDL? Atherosclerosis 1993; 99: 107–120.
   PubMed Web of Science ®Google Scholar
• Fukushima T, Nixon JC. Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem 1980; 102: 176–188.
   PubMed Web of Science ®Google Scholar
• Schwende H, Fitzke E, Ambs P, Dieter P. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,2-dihydroxyvitamin D,. J Leukoc Biol 1996; 59: 555–561.
   PubMed Web of Science ®Google Scholar
• Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26: 171–176.
   PubMed Web of Science ®Google Scholar
• Fong LG, Parthasarathy S, Witztum JL, Steinberg D. Nonenzymatic oxidative cleavage of peptide bonds in apoproteinB-100. J Lipid Res 1987; 28: 1466–1477.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Jurgens G. Mechanistic and genetic aspects of susceptibility of LDL to oxidation. Curr Opin Lipidol 1993; 4: 114–124.
   Google Scholar
• Baoutina A, Dean RT, Jessup W. Trans-plasma membrane electron transport induces macrophage mediated low density lipoprotein oxidation. FASEB J2001; 15: 1580–1582.
   PubMed Web of Science ®Google Scholar
• Werner ER, Hirsch-Kauffmann M, Fuchs D, Hausen A, Reibnegger G, Wachter H. Interferon-y induced degradation of tryptophan by human cells in vitro. Biol Chem Hoppe-Seyler 1987; 368: 1407-1412.
   Google Scholar
• Christen S, Thomas SR, Garner B, Stocker R. Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation: Participation of tryptophan metabolism along the kynurenine pathway. J Clin Invest 1994; 93: 2149–2158.
   PubMed Web of Science ®Google Scholar
• Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment. Cancer Res 1990; 50: 2863–2867.
   PubMed Web of Science ®Google Scholar
• Iwagaki H, Hizuta A, Kobashi K, Isozaki H, Takakura N, Tanaka N. Clinical value of neopterin in infectious complications. Pteridines 1999; 10: 20–23.
   Web of Science ®Google Scholar
• Weiss G, Fuchs D, Hausen A et al. Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp Hematol 1992; 20: 605–610.
   PubMed Web of Science ®Google Scholar